Our laboratory’s interest is in mucosal immunology and the gut microbiota. We mechanistically interrogate the role of microbes and their metabolites in shaping susceptibility and resistance to diseases, including cancer, inflammatory bowel diseases, and kidney diseases.
More than a decade after removal of an adenoma—a precancerous mass—from the colon, alterations to the gut microbiome and metabolites remain and may drive heightened risk of colorectal cancer, according to a new Harvard Chan School study.
Wendy Garrett, Irene Heinz Given Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, has been elected to the National Academy of Medicine (NAM). Election…
